Experience
MannKind to Acquire scPharmaceuticals for up to $360 Million
August 25, 2025
Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on its definitive merger agreement to acquire scPharmaceuticals for up to $360 million
Related contacts
Barbara Borden
Senior Counsel, San Diego
Rowook Park
Partner, San Diego
Julia Kim
Special Counsel, New York
Mischi a Marca
Partner, San Francisco
Adam J. Longenbach
Partner, New York
Matthew S. Scarano
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Todd Gluth
Partner, San Diego
Eric Greig
Partner, Washington, DC
Asa Henin
Partner, San Diego
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Stella Sarma
Partner, Brussels
Charity Williams
Partner, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Emily Mason
Special Counsel, Santa Monica
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Sharon Davidov
Associate, New York
Jameson Davis
Associate, Boston
Athina Gaki
Associate, Brussels
Tony P. Guan
Associate, Santa Monica
Josh Himmelstern
Associate, San Diego
Michelle Hunt
Associate
Wyatt Kernell
Associate, Colorado
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Jacob R. Lahana
Associate, Santa Monica
Eileen Leman
Associate, Los Angeles
Walter Musgrave
Associate, San Diego
Joseph Perry
Associate, Reston
Allie Pilmer
Associate, San Diego
Breanna Qin
Associate, Palo Alto
Vittoria Rainone
Associate, San Diego
Bartholomäus Regenhardt
Associate, Brussels
Brittany K. Wightman
Associate, San Diego
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Related Practices & Industries
Blue Owl Capital Invests up to $262.5 Million in ITM Isotope Technologies Munich SE
May 27, 2025
Cooley advised Blue Owl Capital (NYSE: OWL), an asset manager redefining alternatives, on an up to $262.5 million term loan facility for ITM Isotope Technologies Munich SE, a radiopharmaceutical biotech company dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors.
Related contacts
Michael Tollini
Partner, Washington, DC
Addison Pierce
Partner, Chicago
Dr. Jon Cousin
Partner, Washington, DC
Geoffrey Spolyar
Partner, Boston
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Steve Flores
Partner, Chicago
Susan Piascik Christoff
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Matt Kong
Associate, San Francisco
Dr. Asako Kubota
Associate, Washington, DC
Allison Kutner
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Charles A. Watkins II
Associate, Santa Monica
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Margie Murphy
Paralegal Specialist, New York
Larry Teague
Patent Agent, Seattle
Related Practices & Industries
Nuvation Bio Announces up to $250 Million Nondilutive Financings From Sagard Healthcare Partners
February 18, 2025
Cooley advised Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, on its nondilutive financings of up to $250 million with Sagard Healthcare Partners.
Related contacts
Mischi a Marca
Partner, San Francisco
Addison Pierce
Partner, Chicago
Shimeng Cheng
Special Counsel, San Francisco
Kenneth Guernsey
Senior Counsel , San Francisco
Charles A. Watkins II
Associate, Santa Monica
Dr. Jon Cousin
Partner, Washington, DC
Christophe Beauduin
Partner, New York
Sonia Nath
Partner, Washington, DC
Aaron Pomeroy
Partner, Colorado
Eileen Marshall
Partner, Washington, DC
Michael Neumeister
Partner, Los Angeles
Francis Wheeler
Senior Counsel, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Melissa H. Boyd
Associate, San Francisco
Cara Buchicchio
Associate, New York
Jameson Davis
Associate, Boston
Auguste Humphries
Associate, Washington, DC
Rick Jantz
Associate, Santa Monica
Allison Kutner
Associate, New York
Shelby Saunders
Associate, New York
Dr. Jason Valentine
Associate, Washington, DC
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Related Practices & Industries
Geron Corporation Announces up to $375 Million in Funding With Royalty Pharma and Pharmakon Advisors
Geron Corporation Announces up to $375 Million in Funding With Royalty Pharma and Pharmakon Advisors
November 7, 2024
Cooley advised Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, on its up to $375 million in synthetic royalty and debt financings with Royalty Pharma and Pharmakon Advisors.
Related contacts
Mischi a Marca
Partner, San Francisco
Shimeng Cheng
Special Counsel, San Francisco
Addison Pierce
Partner, Chicago
Chadwick Mills
Partner, San Francisco
Dr. Jon Cousin
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Jennifer Raab
Partner, Palo Alto
Ryan Blair
Partner, San Diego
Phil Mitchell
Partner, New York
Francis Wheeler
Senior Counsel, Colorado
Andrew Epstein
Special Counsel, Seattle
Marina Remennik
Special Counsel, Palo Alto
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
John Forrest
Associate, Boston
Xueqing Li
Associate, San Francisco
Leo Spicer-Phelps
Partner, London
Dr. Jason Valentine
Associate, Washington, DC
Charles A. Watkins II
Associate, Santa Monica
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Chris Rhem
Paralegal Specialist, San Francisco
Related Practices & Industries
Cooley Advises Uber on $5 Billion Investment-Grade Revolving Credit Facility
October 2, 2024
Cooley advised Uber Technologies on its $5 billion investment-grade revolving credit facility.
Related contacts
Mischi a Marca
Partner, San Francisco
Matt Kong
Associate, San Francisco
Xueqing Li
Associate, San Francisco
Jason Savich
Partner, San Francisco
Ellie Seber
Partner, Santa Monica
Addison Pierce
Partner, Chicago
Eileen Marshall
Partner, Washington, DC
David Peinsipp
Partner, San Francisco
Timothy Shapiro
Partner, Palo Alto
David Wilson
Partner, London
Francis Wheeler
Senior Counsel, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Siana Lowrey
Of Counsel
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Chris Rhem
Paralegal Specialist, San Francisco
Related Practices & Industries
Related news and events
Press Release
Blue Owl Capital Extends up to $500 Million in Senior Secured Credit to Madrigal Pharmaceuticals
July 22, 2025
Press Release
Blue Owl Capital Invests up to $262.5 Million in ITM Isotope Technologies Munich SE
May 27, 2025